Specifically, we showed that Cdk4-E2F3-PGC-1α signals preferentially increase oxidative myofibers in skeletal muscle and stimulate mitochondrial biogenesis and bioenergetics, enabling greater exercise capacity, improved glucose tolerance, and protection from diabetes and obesity. The gene discussed is E2F3; the disease is obesity due to melanocortin 4 receptor deficiency.